0001209191-23-013695.txt : 20230228
0001209191-23-013695.hdr.sgml : 20230228
20230228164444
ACCESSION NUMBER: 0001209191-23-013695
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230224
FILED AS OF DATE: 20230228
DATE AS OF CHANGE: 20230228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ambrose Kristen
CENTRAL INDEX KEY: 0001856587
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 23686411
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-24
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001856587
Ambrose Kristen
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Chief Accounting Officer
Common Stock
2023-02-24
4
F
0
502
289.12
D
8510
D
Common Stock
2023-02-27
4
S
0
982
287.25
D
7528
D
Common Stock
2023-02-27
4
S
0
183
288.68
D
7345
D
Common Stock
2023-02-27
4
S
0
42
289.63
D
7303
D
Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1.
Ms. Ambrose undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $287.25 (range $286.79 to $287.71).
Open market sales reported on this line occurred at a weighted average price of $288.68 (range $288.24 to $289.17).
/s/ Joy Liu, Attorney-in-Fact
2023-02-28